mots c retatrutide + MOTS-c Peptide Stack Guide: Dosing, Reconstitution & Safety (2026) Retatrutide, MOTS-C & Insulin resistance

North America led the market in 2024 with over 50.14% share, generating around USD 5.4 Billion in revenue

Individually wrapped, each sachet contains 2 under eye Lint Free Gel patches

Read more Be Well

Key safety observations from available trial data include: Elevated resting heart rate in a dose-dependent manner Gastrointestinal adverse effects (nausea, vomiting, diarrhoea) as the most common side effects, consistent with the GLP-1 receptor agonist class [1] [3] No clinically significant QT interval prolongation was reported in available data, though the extent of formal thorough QT assessment has not been fully detailed in published sources

How do the medications work differently

An additional 3.5% surcharge will be added to payments for services made with credit cards